Page last updated: 2024-10-22

alendronate and Hyperuricemia

alendronate has been researched along with Hyperuricemia in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korkmaz, C1

Other Studies

1 other study available for alendronate and Hyperuricemia

ArticleYear
Should we routinely evaluate serum alkaline phosphatase levels in patients with gout?
    Rheumatology international, 2011, Volume: 31, Issue:11

    Topics: Alendronate; Alkaline Phosphatase; Allopurinol; Biomarkers; Colchicine; Drug Therapy, Combination; G

2011